Gayathri Anandappa

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial

Khurum Khan, David Cunningham, Benjamin Werner et al. · Cancer Discovery · 2018 · 233 citations · Full text

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

Sheela Rao, Gayathri Anandappa, Jaume Capdevila et al. · ESMO Open · 2022 · 69 citations · Full text

miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial

Gayathri Anandappa, Andrea Lampis, David Cunningham et al. · Clinical Cancer Research · 2019 · 45 citations · Full text

Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition–Induced Hypertension

Kaisa Mäki-Petäjä, Adam McGeoch, Lucy Yang et al. · Hypertension · 2021 · 38 citations · Full text

Visual Language, Hypertension, Cardiovascular Disease +12

Minimal residual disease (MRD) detection with circulating tumor DNA (ctDNA) from personalized assays in stage II-III colorectal cancer patients in a U.K. multicenter prospective study (TRACC).

Gayathri Anandappa, Naureen Starling, Ruwaida Begum et al. · Journal of Clinical Oncology · 2021 · 30 citations

Surgical Oncology, Cancer Management, Diagnosis +18